Bei Wang

Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction

Stephen J. Nicholls, Yu Kataoka, Steven E. Nissen et al. · JACC. Cardiovascular imaging · 2022 · 392 citations

Coronary Plaque Phenotype, Cardiovascular Disease, Atherosclerosis +12

Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease

Michelle L. O’Donoghue, Robert P. Giugliano, Stephen D. Wiviott et al. · Circulation · 2022 · 349 citations · Full text

Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE

Prakriti Gaba, Michelle L. O’Donoghue, Jeong‐Gun Park et al. · Circulation · 2023 · 150 citations

Multi-Tissue Acceleration of the Mitochondrial Phosphoenolpyruvate Cycle Improves Whole-Body Metabolic Health

Abudukadier Abulizi, Rebecca Cardone, Romana Stark et al. · Cell Metabolism · 2020 · 75 citations · Full text

Whole-body Metabolic Health, Energy Metabolism, Biochemistry +12

Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT

Raúl D. Santos, Andrea Ruzza, G. Kees Hovingh et al. · The Lancet Diabetes & Endocrinology · 2022 · 47 citations

Lipid Disorder, Heterozygous Familial Hypercholesterolaemia, Inherited Metabolic Disease +7